Chappell 2020
Chappell 2020
Chappell 2020
Reinnervation for
Treatment of Neuro pathic Pain
Ava G. Chappell, MD, Sumanas W. Jordan, MD, PhD,
Gregory A. Dumanian, MD*
KEYWORDS
Neuropathic pain Neuroma Targeted muscle re innervation Chronic postoperative pain
Phantom limb pain
KEY POINTS
Targeted muscle reinnervation (TMR) is a reproducible technique for effective treatment and pre-
vention of neuropathic pain.
The fundamental concept of TMR is to give severed nerve endings a place to go and something to
do, which facilitates healing of these severed peripheral nerves.
Methods to encourage normal healing of severed peripheral nerves instead of burying the nerve
ending in surrounding tissue, will lead to improved outcomes of neuroma treatment.
Neuropathic pain is a surgically treatable condition.
pain include minimally invasive treatments of the First performed by the senior author G.A. Duma-
injured nerve with radiofrequency ablation, nian in 2002, TMR is defined as the coaptation of
Division of Plastic Surgery, Department of Surgery, Northwestern Feinberg School of Medicine, 675 North
Street Clair, Suite 19-250, Chicago, IL 60611, USA
* Corresponding author.
E-mail address: gdumania@nm.org
Twitter: @gregdumanian (G.A.D.)
Table 1
Classifications of peripheral nerve injury
cut peripheral nerves to a newly divided nearby outcomes from nonamputees with neuroma pain
motor nerve branch.14 The fascicles of the prox- who were treated with TMR are better than those
imal nerve grow into motor end plates, and likely who were treated with standard neuroma excision
into proprioceptors and other sensory end organs, and hiding.18–20 There is growing acceptance for
to reinnervate the target muscle.15,16 TMR has TMR as an effective surgical strategy for manage-
evolved from a technique to improve intuitive pros- ment of neuropathic pain. TMR may be performed
thesis control in amputees to a technique to treat by any surgeon with knowledge of peripheral nerve
and prevent neuropathic pain from peripheral anatomy and nerve dissection experience.
neuroma. A recent randomized clinical trial in the
treatment of chronic postamputation pain demon- PATHOPHYSIOLOGY
strated that healing a nerve ending with TMR had
better patient-reported outcomes for residual limb Traumatic neuromas are regions of nerve swelling/
pain and phantom limb pain at 18 months of inflammation that can occur in any part of the body
follow-up, compared with neuroma excision and after nerve injury. Nerve injury can be direct—tran-
muscle burying.17 Furthermore, a cohort study of section during dissection, or indirect—stretched
patients who underwent TMR at the time of amputa- or crushed during retraction. The physiologic
tion compared with unselected amputees from the response to axonal injury is axon sprouting and
general population demonstrated significantly fewer regeneration from the proximal segment and wal-
TMR patients with moderate to severe residual limb lerian degeneration of the distal segment. Sed-
and phantom limb pain by multiple measures.9 don’s classification distinguishes types of nerve
Additional clinical data have shown that pain injury in terms of neuropraxia, axonotmesis, and
TMR for Neuropathic Pain 3
Fig. 1. TMR nerve transfers for BKA. Under loupe magnification (2.5), the tibial nerve was divided and coapted
to the motor nerve to the soleus with 6-0 Prolene interrupted sutures (yellow background). The common pero-
neal nerve was transposed medial to lateral gastrocnemius tendon and coapted to the lateral gastrocnemius mo-
tor nerve and the motor nerve to the lateral gastrocnemius (vessel loops at the top). The 2 components of the
sural nerve were coapted to 2 separate motor nerves to the medial gastrocnemius muscle. The total tourniquet
time was 45 minutes.
neurotmesis.21 Sunderland further grades nerve Histologically, TMR restores axon count, size,
injury based on expected recovery. With intact and myelination in a rabbit amputation model.23 In
or repaired perineurium and epineurium, sprout- the authors’ clinical experience, reestablishment
ing axons find a distal target and eventually of muscle function can be detected clinically in
prune excess axons. For Sunderland grade 4 or more than 95% of nerve transfers.23 Electromyog-
greater, however, sprouting axons fail to connect raphy after transhumeral TMR has demonstrated
to a distal segment or target organ and become physiologic synaptic inputs to reinnervated mus-
encased in scar, thus forming neuromas, specif- cles.24 What is unclear is the fascicles that fail to
ically neuroma-in-continuity in axonotmesis or find a distal target after nerve transfer due to
end neuroma in neurotmesis (Table 1).21 obvious mismatch in size and fascicle numbers be-
Within the neuroma bulb, the authors’ data have tween donor and recipient nerves. This size
shown that the axons are sensory, with no motor mismatch undoubtedly led to the slow adoption
staining found.22 The model is that the sensory of TMR as a surgical technique. It is hypothesized
nerves continue to seek a distal nerve attempting that the large denervated block of muscle near
to heal and reinnervate, whereas without Schwann the nerve coaptation site is a source of additional
cells and other trophic factors, the motor axons end organs to soak up escaping axons.
recede back toward the spine.22 This is consistent
with clinical peripheral nerve surgery that motor PRESENTATION AND DIAGNOSIS
outcomes tend to be less successful than sensory
recoveries for mixed nerve repairs. Furthermore, it A typical patient presenting with a symptomatic
has been the authors’ experience that cut pure neuroma may describe the pain as electric, shoot-
motor nerves do not form neuromas, a key to TMR. ing, or burning. The pain may be associated with
4 Chappell et al
light touch or pressure or changes in weather and For the patient who presents with intolerable
temperature or be without any provocation at all. symptomatic neuroma, the clinician must address
Neuropathic pain may affect sleep quality, such the nerve injury. Symptomatic neuromas by defini-
as the common complaint of night waking in carpal tion are associated with injury to a mixed or sen-
tunnel syndrome; mood; ambulation; and, for the sory nerve. The clinical diagnosis is made as a
amputee, prosthetic use. Patients may present combination of the chief complaint as chronic
with high opioid tolerances. For the amputee, pain postamputation/surgery/injury and a focused
postamputation pain may include residual limb physical examination. The clinician asks patients
(or stump) pain, phantom limb pain, back pain, to point to a location on their extremity where the
and hip pain.25,26 To clarify distinctions between pain is the greatest, and the patients can quickly
pain syndromes, residual limb pain is defined as identify this painful spot. There likely is a Tinel
pain local to the residual limb, often due to a neu- sign when this spot is tapped by the clinician, or
roma27; phantom limb pain is defined as unpleas- patients may experience severe acute pain when
ant or painful sensations perceived in the missing this region is palpated. The nerve leading to this
limb, thought to be a complex interplay between neuroma often is excitable to palpation along its
the neuroma and several levels of the central ner- length. Imaging typically is not necessary or rec-
vous system28–30; and chronic pain is defined as ommended for the work-up of intolerable neuro-
pain lasting greater than 6 months and causing pathic pain.
physical debilitation and decreased quality of Injections with local anesthesia may be per-
life.31 A simple history for pain includes an assess- formed to confirm that treatment of the injured
ment of intensity on an 11-point numerical rating nerve will lead to a change in symptoms. An
scale (0 is no pain and 10 is the worst pain imagin- inability to improve symptoms temporarily with
able) and an assessment of frequency. an anesthetic injection should give both surgeon
Fig. 2. Case example, a 68-year-old woman one year post op left below knee amputation presented with persis-
tent left leg pain in the common peroneal nerve distribution. Despite medical treatment with hydrocodone and
gabapentin, her residual limb pain and phantom limb pain were severe, and she was unable to tolerate wearing a
prosthesis. After discussion of risks and benefits, she wished to pursue with TMR surgery for her chronic postam-
putation pain and phantom limb pain. Prior to nerve transfers from a midline posterior incision, donor nerves are
prepared (right, from top of figure to bottom): the common peroneal nerve, the peroneal component of the su-
ral nerve, and the tibial component of sural nerve. The tibial nerve in the center of the field has not undergone
neurotomy. Recipient motor branches are shown with vessel loops (from top to bottom): motor nerve to the
lateral gastrocnemius, motor nerve to the flexor hallucis longus (FHL), and 2 motor branches to the medial
gastrocnemius. The motor nerve to the soleus is in the center of the field.
TMR for Neuropathic Pain 5
Table 5 Table 7
Donor nerves and possible motor nerve targets Donor nerves and possible motor nerve targets
for shoulder disarticulation nerve transfer for transradial nerve transfer
Nerve Primary Muscle Target Donor Sensory Nerve Primary Muscle Target
Median Medial head of biceps Deep peroneal Extensor digitorum
Ulnar Brachialis longus
Radial Lateral head of triceps Superficial Peroneus longus
peroneal
Medial antebrachial Any local muscles
cutaneous/lateral Lateral sural Lateral gastrocnemius
antebrachial Medial sural Lateral or medial
cutaneous gastrocnemius
TMR for Neuropathic Pain 7
Fig. 3. TMR for treatment of recurrent ilioinguinal neuroma. The neuroma is excised and the freshened ending of
the ilioinguinal nerve coapted to a freshly divided motor nerve to the internal oblique.
compressive dressings. A splint or other additional between 50% and 90% of amputees.25,26 Symp-
form of immobilization is not needed. Patients can tomatic neuromas are a major driver of residual
restart wearing their original prosthesis when their limb pain and phantom limb pain.36 Moreover,
surgical incisions are healed and postoperative symptomatic neuromas may occur with any injury
edema has resolved, at approximately 4 weeks to mixed and sensory peripheral nerves. Funda-
to 6 weeks after surgery.35 It is important that pa- mentally, the injured sensory axons are sprouting
tients are informed prior to surgery that after sur- in an attempt to find an end organ. Modern tech-
gery they may experience numbness in the niques, including nerve repair, nerve autografts
residual limb, dysesthesia, and even transfer and allografts, regenerative peripheral nerve inter-
sensation in the skin over reinnervated muscles. faces, and TMR, all aim to satisfy the need for an
Additionally, for patients with phantom limb pain, end organ.8,10,18 TMR resolves sprouting and
some may have an exacerbation of symptoms associated painful symptoms by direct nerve-to-
lasting up to 4 weeks to 6 weeks after surgery until nerve healing.
new nerve connections have formed.32 Internal Recent studies have shown that TMR can
data support the improvement in established address the chronic postamputation pain prob-
phantom limb pain approximately 6 months after lem. TMR results in clinically meaningful improve-
TMR. ment in residual limb and phantom limb pain by an
For patients presenting for TMR at the time of average of 3.7 and 3.6 of 10 points, respectively, at
amputation, postoperative care and discharge last follow-up.17 TMR has shown improvement in
planning are dictated by needs related to the postamputation neuroma pain even months to
amputation itself. No special instructions are years after the initial amputation, although learned
necessary because of the TMR portion of the behaviors from chronic pain are difficult to
case. Once evidence of muscle reinnervation has reverse.17,37 As a prophylactic measure, TMR per-
occurred, the patient may practice contracting formed at the time of initial amputation leads to
the reinnervated muscles. significantly lower residual limb and phantom
limb pain scores (1 of 10 for both) compared with
DISCUSSION the general amputee population (4 of 10 and 5 of
10, respectively).9 TMR more than doubled the
Postamputation pain syndromes may include re- proportion of amputees reporting zero pain and
sidual limb pain, phantom limb pain, back pain, nearly halved the proportion of amputees report-
and hip pain and are a significant concern for the ing severe pain (7–10 of 10).9 Thus, the indication
amputee population, with prevalence ranging for TMR extends beyond prosthesis control for
8 Chappell et al
upper extremity amputees and includes the treat- 7. Bittar RG, Otero S, Carter H, et al. Deep brain stim-
ment and prevention of symptomatic neuroma ulation for phantom limb pain. J Clin Neurosci 2005;
pain in amputees and nonamputees. 12(4):399–404.
8. Kubiak CA, Kemp SWP, Cederna PS. Regenerative
SUMMARY peripheral nerve interface for management of post-
amputation neuroma. JAMA Surg 2018;153(7):
Postoperative neuropathic pain causes chronic 681–2.
disability to many people globally. As access to 9. Valerio IL, Dumanian GA, Jordan SW, et al. Preemp-
surgical care increases, clinicians must be aware tive treatment of phantom and residual limb pain
of the potential postoperative pain complications. with targeted muscle reinnervation at the time of ma-
Chronic neuroma pain frequently is misdiagnosed, jor limb amputation. J Am Coll Surg 2019;228(3):
overlooked, or masked with opioids. Surgical 217–26.
techniques and principles from TMR can apply to 10. Woo SL, Kung TA, Brown DL, et al. Regenerative pe-
successfully treat neuroma pain at sites of ampu- ripheral nerve interfaces for the treatment of postam-
tation as well as other postsurgical sites. putation neuroma pain: a pilot study. Plast Reconstr
Surg Glob Open 2016;4(12):e1038.
CODING 11. Kung TA, Langhals NB, Martin DC, et al. Regenera-
tive peripheral nerve interface viability and signal
transduction with an implanted electrode. Plast Re-
International D36.10 Neuroma
constr Surg 2014;133(6):1380–94.
Classification
of Diseases, Tenth 12. Mackinnon SE, Dellon AL, Hudson AR, et al. Alter-
Revision ation of neuroma formation by manipulation of its
Current Procedural 64905 Nerve pedicle microenvironment. Plast Reconstr Surg 1985;76(3):
Terminology transfer, first stage 345–53.
64910 Neuroma excision 13. Boldrey E. Amputation neuroma in nerves implanted
in bone. Ann Surg 1943;118(6):1052–7.
14. hijiawi JKT, Lipschutz. An improved brain-machine
interface accomplished using multiple nerve trans-
fers. Plast Reconstr Surg 2006;118:1573–8.
DISCLOSURE 15. Kuiken TA, Dumanian GA, Lipschutz RD, et al. The
Dr G.A. Dumanian has consulted for the Check- use of targeted muscle reinnervation for improved
point Surgical Company and has received support myoelectric prosthesis control in a bilateral shoulder
for his teaching course for Targeted Muscle Rein- disarticulation amputee. Prosthet Orthot Int 2004;
nervation. Dr S.W. Jordan and Dr A.G. Chappell 28(3):245–53.
have nothing to disclose. 16. Kuiken TA, Miller LA, Lipschutz RD, et al. Targeted
reinnervation for enhanced prosthetic arm function
in a woman with a proximal amputation: a case
REFERENCES
study. Lancet 2007;369(9559):371–80.
1. Vernadakis AJ, Koch H, Mackinnon SE. Manage- 17. Bi A, Park E, Dumanian GA. Treatment of painful
ment of neuromas. Clin Plast Surg 2003;30(2): nerves in the abdominal wall using processed nerve
247–68, vii. allografts. Plast Reconstr Surg Glob Open 2018;
2. Huse E, Larbig W, Flor H, et al. The effect of opioids 6(3):e1670.
on phantom limb pain and cortical reorganization. 18. Eberlin KR, Ducic I. Surgical algorithm for neuroma
Pain 2001;90(1–2):47–55. management: a changing treatment paradigm. Plast
3. Baron R. Neuropathic pain: a clinical perspective. Reconstr Surg Glob Open 2018;6(10). https://doi.
Handb Exp Pharmacol 2009;(194):3–30. org/10.1097/GOX.0000000000001952.
4. Moore A. Gabapentin and post tonsillectomy pain- 19. Wolvetang NHA, Lans J, Verhiel S, et al. Surgery for
the next best thing? Arch Trauma Res 2013;1(4): symptomatic neuroma: anatomic distribution and
188–90. predictors of secondary surgery. Plast Reconstr
5. Wiffen PJ, Derry S, Moore RA, et al. Carbamazepine Surg 2019;143(6):1762–71.
for chronic neuropathic pain and fibromyalgia in 20. Guse DM, Moran SL. Outcomes of the surgical treat-
adults. Cochrane Database Syst Rev 2014;(4): ment of peripheral neuromas of the hand and fore-
CD005451. arm: a 25-year comparative outcome study. Ann
6. Eccleston C, Hearn L, Williams AC. Psychological Plast Surg 2013;71(6):654–8.
therapies for the management of chronic neuro- 21. Kaya Y, Sarikcioglu L. Sir Herbert Seddon (1903-
pathic pain in adults. Cochrane Database Syst Rev 1977) and his classification scheme for peripheral
2015;(10):CD011259. nerve injury. Childs Nerv Syst 2015;31(2):177–80.
TMR for Neuropathic Pain 9
22. Agnew SP, Ko J, De La Garza M, et al. Limb trans- 31. Rudy TE, Lieber SJ, Boston JR, et al. Psychosocial
plantation and targeted reinnervation: a practical predictors of physical performance in disabled indi-
comparison. J Reconstr Microsurg 2012;28(1):63–8. viduals with chronic pain. Clin J Pain 2003;19(1):
23. Kim PS, Ko JH, O’Shaughnessy KK, et al. The ef- 18–30.
fects of targeted muscle reinnervation on neuromas 32. Gart MS, Souza JM, Dumanian GA. Targeted muscle
in a rabbit rectus abdominis flap model. J Hand reinnervation in the upper extremity amputee: a
Surg Am 2012;37(8):1609–16. technical roadmap. J Hand Surg Am 2015;40(9):
24. Farina D, Castronovo AM, Vujaklija I, et al. Common 1877–88.
synaptic input to motor neurons and neural drive to
33. Morgan EN, Kyle Potter B, Souza JM, et al. Targeted
targeted reinnervated muscles. J Neurosci 2017;
muscle reinnervation for transradial amputation:
37(46):11285–92.
description of operative technique. Tech Hand Up
25. Ephraim PL, Wegener ST, MacKenzie EJ, et al.
Extrem Surg 2016;20(4):166–71.
Phantom pain, residual limb pain, and back pain in
amputees: results of a national survey. Arch Phys 34. Fracol ME, Janes LE, Ko JH, et al. Targeted muscle
Med Rehabil 2005;86(10):1910–9. reinnervation in the lower leg: an anatomical study.
26. Sadosky A, McDermott AM, Brandenburg NA, et al. Plast Reconstr Surg 2018;142(4):541e–50e.
A review of the epidemiology of painful diabetic pe- 35. Kuiken TA, Li G, Lock BA, et al. Targeted muscle re-
ripheral neuropathy, postherpetic neuralgia, and innervation for real-time myoelectric control of multi-
less commonly studied neuropathic pain conditions. function artificial arms. JAMA 2009;301(6):619–28.
Pain Pract 2008;8(1):45–56. 36. Vaso A, Adahan HM, Gjika A, et al. Peripheral ner-
27. Buchheit T, Van de Ven T, Hsia HL, et al. Pain pheno- vous system origin of phantom limb pain. Pain
types and associated clinical risk factors following 2014;155(7):1384–91.
traumatic amputation: results from Veterans Inte- 37. Souza JM, Cheesborough JE, Ko JH, et al. Targeted
grated Pain Evaluation Research (VIPER). Pain muscle reinnervation: a novel approach to postam-
Med 2016;17(1):149–61. putation neuroma pain. Clin Orthop Relat Res
28. Flor H, Elbert T, Knecht S, et al. Phantom-limb pain 2014;472(10):2984–90.
as a perceptual correlate of cortical reorganization
38. Seddon HJ. The use of autogenous grafts for the
following arm amputation. Nature 1995;375(6531):
repair of large gaps in peripheral nerves. The British
482–4.
Journal of Surgery 1947;35(138):151–67.
29. Flor H, Nikolajsen L, Staehelin Jensen T. Phantom
limb pain: a case of maladaptive CNS plasticity? 39. Sunderland S. Nerve Injuries and Their Repair: A
Nat Rev Neurosci 2006;7(11):873–81. Critical Appraisal. New York: Churchill Livingstone;
30. Jensen TS, Krebs B, Nielsen J, et al. Phantom limb, 1991.
phantom pain and stump pain in amputees during 40. Mackinnon S, Dellon AL. Diagnosis of nerve injury.
the first 6 months following limb amputation. Pain Surgery of the peripheral nerve. New York: Thieme;
1983;17(3):243–56. 1988. p. 74–8.